Adaptive Biotechnologies Corp — Director's Dealing 2020

Aug 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-08-04

Reporting Person: BENZENO SHARON (Chief Business Development Off)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-04	Common Stock	M	2604	$6.55	Acquired	2604	Direct
2020-08-04	Common Stock	M	2604	$6.55	Acquired	5208	Direct
2020-08-04	Common Stock	M	1562	$7.27	Acquired	6770	Direct
2020-08-04	Common Stock	M	417	$6.32	Acquired	7187	Direct
2020-08-04	Common Stock	S	7187	$40.00	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-04	Stock Option (Right to Buy)	$6.55	M	2604	Disposed	2028-02-07	Common Stock (2604)	Direct
2020-08-04	Stock Option (Right to Buy)	$6.55	M	2604	Disposed	2028-10-01	Common Stock (2604)	Direct
2020-08-04	Common Stock (Right to Buy)	$7.27	M	1562	Disposed	2029-02-07	Common Stock (1562)	Direct
2020-08-04	Common Stock	$6.32	M	417	Disposed	2026-09-16	Common Stock (417)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020.

F2: The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F3: The options vested with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F4: The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F5: The option is vested and fully exercisable.